We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




LGC Standards Opens First Chinese Office

By LabMedica International staff writers
Posted on 29 Apr 2009
LGC Standards (Teddington, UK) has opened its first office in Beijing, China, signaling a milestone in the company's international development. More...
The new office will enable the company to bring its range of laboratory quality products and services to the Chinese market.

LGC Standards provides a range of products and services for measurement and laboratory control through the quick and efficient supply of reference materials and proficiency testing schemes. The company will be able to support Chinese laboratories directly by offering logistical and technical advice in their local language.

Dr Matthias Brommer, director, LGC Standards said: "The opening of our first Chinese office clearly demonstrates that LGC Standards is committed to providing global quality management solutions for laboratories worldwide. Our Chinese team will focus on supplying laboratories in the pharmaceutical, environmental, food, industrial, and forensic sectors with reference materials and proficiency testing schemes to support laboratory quality."

In welcoming LGC China to the Group, David Richardson, Chief Executive of LGC, commented, "Our new office provides an excellent opportunity for LGC to serve the Chinese scientific community and gives us a base from which to partner with local businesses on future projects. Our investment strengthens LGC's position as an international leader in reference materials.”

The company supplies over 20,000 reference materials, pharmaceutic impurity reference standards, proficiency testing and training in analytical quality. LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, and the UK, a joint venture presence in India, and representatives in Bulgaria, Czech Republic, Finland, Hungary, Ireland, Romania, Turkey, and the United States.

LGC is an international science-based company and market leader in diagnostic, analytical, and forensic services and reference standards. A progressive and innovative enterprise, LGC operates in socially responsible fields underpinning the safety, health, and security of the public and the regulation of industry, for U.K. government departments, and blue chip clients.

Related Links:

LGC Standards




Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DROP-AD in-house collection and extraction protocol and testing procedures (Huber, H., Montoliu-Gaya, L., Brum, W.S. et al.; Nat Med (20256); doi.org/10.1038/s41591-025-04080-0)

At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers

Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.